Palatin Technologies, Inc. Common Stock (PTN) - Net Assets

Latest as of March 2026: $10.59 Million USD

Based on the latest financial reports, Palatin Technologies, Inc. Common Stock (PTN) has net assets worth $10.59 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($13.23 Million) and total liabilities ($2.63 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PTN intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets $10.59 Million
% of Total Assets 80.09%
Annual Growth Rate N/A
5-Year Change -109.62%
10-Year Change N/A
Growth Volatility 490.43

Palatin Technologies, Inc. Common Stock - Net Assets Trend (1996–2025)

This chart illustrates how Palatin Technologies, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. See defensive interval ratio of Palatin Technologies, Inc. Common Stock to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Palatin Technologies, Inc. Common Stock (1996–2025)

The table below shows the annual net assets of Palatin Technologies, Inc. Common Stock from 1996 to 2025. For live valuation and market cap data, see PTN market cap overview.

Year Net Assets Change
2025-06-30 $-4.78 Million -4184.46%
2024-06-30 $-111.50K +94.37%
2023-06-30 $-1.98 Million -112.17%
2022-06-30 $16.27 Million -67.24%
2021-06-30 $49.65 Million -38.07%
2020-06-30 $80.17 Million -20.27%
2019-06-30 $100.55 Million +272.89%
2018-06-30 $26.96 Million +622.11%
2017-06-30 $-5.16 Million +70.63%
2016-06-30 $-17.59 Million -244.09%
2015-06-30 $12.20 Million +24.68%
2014-06-30 $9.79 Million -57.40%
2013-06-30 $22.98 Million +1155.03%
2012-06-30 $1.83 Million -89.94%
2011-06-30 $18.19 Million +95.23%
2010-06-30 $9.32 Million +181.22%
2009-06-30 $3.31 Million -49.43%
2008-06-30 $6.55 Million -64.64%
2007-06-30 $18.53 Million +1.27%
2006-06-30 $18.30 Million +98.37%
2005-06-30 $9.23 Million -52.41%
2004-06-30 $19.39 Million +3.91%
2003-06-30 $18.66 Million +114.77%
2002-06-30 $8.69 Million -27.10%
2001-06-30 $11.92 Million +72.56%
2000-06-30 $6.91 Million +2201.72%
1999-06-30 $300.00K -91.18%
1998-06-30 $3.40 Million -65.31%
1997-06-30 $9.80 Million +245.29%
1996-06-30 $2.84 Million --

Equity Component Analysis

This analysis shows how different components contribute to Palatin Technologies, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 45094096100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock $9.30K %
Other Components $454.29 Million %
Total Equity $-4.78 Million 100.00%

Palatin Technologies, Inc. Common Stock Competitors by Market Cap

The table below lists competitors of Palatin Technologies, Inc. Common Stock ranked by their market capitalization.

Company Market Cap
Devonian Health Group Inc
V:GSD
 $21.12 Million
Japan Gold Corp
V:JG
 $21.13 Million
Cliq Digital AG
F:CLIQ
 $21.15 Million
CKX Lands Inc
NYSE MKT:CKX
 $21.15 Million
The Brand House Collective, Inc.
NASDAQ:TBHC
 $21.11 Million
Vyne Therapeutics Inc
NASDAQ:VYNE
 $21.11 Million
Attica Publications S.A
AT:ATEK
 $21.11 Million
Advanced Connection Corporation Public Company Limited
BK:ACC
 $21.10 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Palatin Technologies, Inc. Common Stock's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -111,497 to -4,777,045, a change of -4,665,548.
  • Net loss of 17,307,349 reduced equity.
  • Share repurchases of 11,359,000 reduced equity.
  • New share issuances of 7,960,765 increased equity.
  • Other comprehensive income increased equity by 179,306.
  • Other factors increased equity by 15,860,730.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $-17.31 Million -362.3%
Share Repurchases $11.36 Million -237.78%
Share Issuances $7.96 Million +166.65%
Other Comprehensive Income $179.31K +3.75%
Other Changes $15.86 Million +332.02%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Palatin Technologies, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1996-06-30 $1182.59 $11.87 x
1997-06-30 $837.89 $11.87 x
1998-06-30 $264.76 $11.87 x
1999-06-30 $12.63 $11.87 x
2000-06-30 $232.00 $11.87 x
2001-06-30 $294.04 $11.87 x
2002-06-30 $152.99 $11.87 x
2003-06-30 $164.45 $11.87 x
2004-06-30 $101.63 $11.87 x
2005-06-30 $42.82 $11.87 x
2006-06-30 $75.80 $11.87 x
2007-06-30 $60.80 $11.87 x
2008-06-30 $19.22 $11.87 x
2009-06-30 $9.59 $11.87 x
2010-06-30 $23.62 $11.87 x
2011-06-30 $22.64 $11.87 x
2012-06-30 $1.31 $11.87 x
2013-06-30 $5.88 $11.87 x
2014-06-30 $2.29 $11.87 x
2015-06-30 $2.52 $11.87 x
2016-06-30 $-2.81 $11.87 x
2017-06-30 $-0.70 $11.87 x
2018-06-30 $3.26 $11.87 x
2019-06-30 $11.58 $11.87 x
2020-06-30 $8.54 $11.87 x
2021-06-30 $5.25 $11.87 x
2022-06-30 $1.70 $11.87 x
2023-06-30 $-0.18 $11.87 x
2024-06-30 $-0.01 $11.87 x
2025-06-30 $-8.87 $11.87 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Palatin Technologies, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-251.07%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1996 -121.20% -17200.00% 0.00x 2.48x $-3.72 Million
1997 -54.08% -757.14% 0.05x 1.44x $-6.28 Million
1998 -291.18% -9900.00% 0.02x 1.91x $-10.24 Million
1999 -4000.00% -2000.00% 0.13x 15.67x $-12.03 Million
2000 -118.51% -159.92% 0.58x 1.29x $-8.87 Million
2001 -88.95% -592.77% 0.13x 1.20x $-11.79 Million
2002 -185.78% -5736.02% 0.02x 1.42x $-17.01 Million
2003 -110.23% -1619.29% 0.06x 1.22x $-22.43 Million
2004 -135.75% -1136.76% 0.09x 1.26x $-28.26 Million
2005 -155.64% -79.96% 0.51x 3.81x $-15.28 Million
2006 -158.25% -146.64% 0.49x 2.19x $-30.79 Million
2007 -149.75% -192.64% 0.34x 2.31x $-29.60 Million
2008 -219.54% -125.26% 0.60x 2.92x $-15.04 Million
2009 -144.93% -42.30% 0.86x 3.98x $-5.13 Million
2010 -19.24% -12.64% 1.14x 1.33x $-2.72 Million
2011 -70.45% -868.61% 0.07x 1.16x $-14.64 Million
2012 -942.33% -23398.58% 0.01x 2.94x $-17.44 Million
2013 -90.79% -201352.90% 0.00x 1.09x $-23.16 Million
2014 -142.29% 0.00% 0.00x 1.28x $-14.91 Million
2015 -144.75% -136.40% 0.44x 2.42x $-18.89 Million
2016 0.00% 0.00% 0.00x 0.00x $-49.95 Million
2017 0.00% -29.81% 0.79x 0.00x $-12.82 Million
2018 91.61% 36.80% 1.72x 1.45x $22.01 Million
2019 35.58% 59.32% 0.58x 1.04x $25.72 Million
2020 -27.92% -18969.53% 0.00x 1.06x $-30.40 Million
2021 -67.61% 0.00% 0.00x 1.36x $-38.53 Million
2022 -220.12% -2438.49% 0.04x 2.22x $-37.43 Million
2023 0.00% -567.44% 0.27x 0.00x $-27.34 Million
2024 0.00% -662.26% 0.42x 0.00x $-29.72 Million
2025 0.00% 0.00% 0.00x 0.00x $-16.83 Million

Industry Comparison

This section compares Palatin Technologies, Inc. Common Stock's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

  • Industry: Biotechnology
  • Average net assets among peers: $296,451,843
  • Average return on equity (ROE) among peers: -36.17%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Palatin Technologies, Inc. Common Stock (PTN) $10.59 Million -121.20% 0.25x $21.12 Million
Aardvark Therapeutics, Inc. Common Stock (AARD) $-34.80 Million 0.00% 0.00x $81.00 Million
Abcellera Biologics Inc (ABCL) $1.15 Billion -12.70% 0.29x $1.55 Billion
Abeona Therapeutics Inc (ABEO) $-17.08 Million 0.00% 0.00x $321.39 Million
Acumen Pharmaceuticals Inc (ABOS) $-18.59 Million 0.00% 0.00x $155.29 Million
Abpro Holdings, Inc. (ABP) $-75.73 Million 0.00% 0.00x $2.00 Million
Absci Corp (ABSI) $176.18 Million -62.76% 0.23x $1.01 Billion
Arbutus Biopharma Corp (ABUS) $97.37 Million -71.81% 0.35x $831.63 Million
ABVC Biopharma Inc (ABVC) $2.46 Million -172.46% 1.68x $33.54 Million
Abivax SA American Depositary Shares (ABVX) $455.01 Million -73.87% 0.28x $7.77 Billion
ACADIA Pharmaceuticals Inc (ACAD) $1.23 Billion 31.86% 0.27x $3.59 Billion

About Palatin Technologies, Inc. Common Stock

NASDAQ:PTN USA Biotechnology
Market Cap
$21.12 Million
Market Cap Rank
#24957 Global
#5252 in USA
Share Price
$11.87
Change (1 day)
-5.04%
52-Week Range
$11.87 - $14.61
All Time High
$14.61
Categories
Companies in USA Biotechnology
About

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, … Read more